Monitor for potential selling pressure as registered shares become tradable; the large block represents ~30% of outstanding shares, which could weigh on near-term stock performance.
Executive Summary
First Tracks Biotherapeutics filed an S-1 registration statement for the resale of up to 10,497,054 shares of common stock by selling stockholders. The company receives no proceeds from this offering. The filing is a routine registration obligation following a private placement in March 2026 that raised approximately $80 million for the company at $13.81 per share.
Key Facts
- Resale of up to 10,497,054 shares by selling stockholders; company receives no proceeds.
- Private placement closed in March 2026: 5,791,479 primary shares sold at $13.81/share, netting ~$80M.
- Post-spin-off and private placement pro forma cash and cash equivalents: $174.8M as of Dec 31, 2025.
- Net loss of $166.1M in 2025 and $163.7M in 2024; no approved products or revenue.
- Stock closed at $17.82 on May 7, 2026; 34,892,381 shares outstanding.
Financial Impact
No proceeds to company; offering of up to 10.5M shares represents ~30% of outstanding shares.
Risk Factors
- Potential downward pressure from selling stockholders liquidating positions.
- No new capital raised; cash runway depends on existing $174.8M.
- Clinical-stage company with no revenue and ongoing losses.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1 Filing (Primary) | 0001193125-26-214778 |
| Document: d53570dex21.htm | 0001193125-26-214778 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers